Home

Martine A. Rothblatt, Chairperson & CEO: United Therapeutics UTHR Sell · Filed 24/07/17

Trade details

Type
Insider sale
Amount
$685,457.3
Shares · price
2,090 sh · $327.97 a share
Held after
1,013 sh
Trade date
24/07/16
Filed
24/07/17
Days to filing
1 days

Sold 67.4% of holdings

Share of holding sold
67.4%

United Therapeutics trades, last 26 weeks

What else happened in United Therapeutics around then

Filed or reported within 30 days of the trade day · 24/06/16~24/08/15

Martine A. Rothblatt's recent trades

  • Martine A. Rothblatt

    Sell10b5-1 planUnited Therapeutics

    $501.5K

    Filed 10/01

  • Martine A. Rothblatt

    Sell10b5-1 planUnited Therapeutics

    $457K

    Filed 10/01

  • Martine A. Rothblatt

    Sell10b5-1 planUnited Therapeutics

    $357.6K

    Filed 10/01

  • Martine A. Rothblatt

    Sell10b5-1 planUnited Therapeutics

    $325.9K

    Filed 10/01

  • Martine A. Rothblatt

    Sell10b5-1 planUnited Therapeutics

    $314.2K

    Filed 10/01

Martine A. Rothblatt, Chairman — sold $685.5K of United Therapeutics UTHR · 67.4% of holdings · 10b5-1 plan | Whalegun